Video

IND Prep Versus Clinical/Commercial Scale-Up In Novel Protein Therapeutics

Source: Bioprocess Online

In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio, Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics, and Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech share detailed considerations for scale-up of complex protein therapeutics, from IND preparation through commercial scale.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online